1. In incubated tubule fragments from renal cortex of fed rats gluconeogenesis from pyruvate was stimulated by adrenaline (1 pM optimum) and by the selective a-adrenergic agonists oxymetazoline and amidephrine. The selective fi-agonists isoproterenol and salbutamol were ineffective at concentrations up to 10pM. 2. Stimulation of gluconeogenesis by 1IpM-adrenaline was almost completely blocked by 10puM-phentolamine (aantagonist), partially blocked by 10uM-phenoxybenzamine (a-antagonist) and unaffected by 10uM-propranolol (fl-antagonist). 3. Adrenaline stimulation of gluconeogenesis was rapid and was sustained for at least 1 h. 4. Oxymetazoline (a-agonist) was extremely potent in stimulation of gluconeogenesis. This compound stimulated glucose production from pyruvate, lactate and glutamate, but not from succinate or glycerol. 5. In the absence of Ca2+ oxymetazoline was ineffective, whereas some stimulatory effect of adrenaline on gluconeogenesis was still observed. 6. Glucagon had no effect on gluconeogenesis from pyruvate in the presence of 1.27mM-Ca2+ and inhibited the process in the presence of 0.25 mM-Ca2+. Parathyrin (parathyroid hormone) stimulated gluconeogenesis at 1.27mM-Ca2+. 7. In short incubations of tubule fragments glucagon, papaverine and adrenaline significantly increased 3': 5'-cyclic AMP. Adrenaline also slightly decreased 3': 5'-cyclic GMP. Oxymetazoline had no effect on the amount of either cyclic nucleotide. 8. At all concentrations tested, theophylline and papaverine decreased gluconeogenesis from pyruvate. 9. It is concluded that renal gluconeogenesis may be increased by a-but not fl-adrenergic stimuli and that this is probably independent of changes in 3': 5'-cyclic AMP or 3': 5'-cyclic GMP. An involvement of Ca2+ in the action of oxymetazoline appears likely, but this is less certain with adrenaline.
Renal gluconeogenesis represents a significant metabolic activity in non-functioning kidney preparations in vitro. The process is localized in the proximal tubule (Guder & Schmidt, 1974) and probably makes immediate localized provision of glucose for other parts of the nephron (McCann, 1962) . Contribution to the glucose supply for body tissues in general is also possible.
Renal-cortex preparations are convenient for investigating the control of gluconeogenesis, since this tissue has an extremely low glycogen content (Krebs, 1963) . In the presence of appropriate substrates, gluconeogenesis can be observed in vitro at rates that related to tissue wet weight, may even exceed those found in liver. Metabolic studies have been carried out mainly in three different systems, incubated cortex slices, the isolated perfused kidney and tubule fragments prepared by collagenase digestion of kidney cortex (Nagata & Rasmussen, 1970a; . In many instances there has been agreement in the results obtained with these different preparations. Vol. 168
Many factors alter renal gluconeogenesis in vitro, e.g. the electrolyte composition ofmedia Rutman et al., 1965; Nagata & Rasmussen, 1970a; , diet , fatty acids (Weidemann &Krebs, 1969; Guder &Wieland, 1972) and several hormones. The observations that parathyrin (parathyroid hormone) or exogenous 3': 5'-cyclic AMP stimulate renal gluconeogenesis, that parathryin can increase renal-cortex 3': 5'-cyclic AMP through the action of a parathyrin-sensitive adenylate cyclase and that actions of parathyrin and 3':5'-cyclic AMP on gluconeogenesis are in some cases non-additive (Pagliara & Goodman, 1969; Nagata & Rasmussen, 1970b; Melson et al., 1970; Kaminsky et al., 1970; Guder & Wieland, 1972) have led to the conclusion that 3': 5'-cyclic AMP acts as a messenger ofthis hormone in this process. In addition observed stimulation of renal gluconeogenesis by glucagon and implicated 3' : 5'-cyclic AMP as a mediator of this hormonal effect. However, this renal action of glucagon could 2 not be demonstrated in the isolated perfused kidney (Nishiitsutsuji-Uwo et al., 1967; Bowman, 1970) .
Just before the start of the present study it was reported that catecholamines stimulated gluconeogenesis in renal-cortex slices (Klahr et al., 1973; Kurokawa & Massry, 1973a) and in isolated tubule fragments (Friedrichs & Schoner, 1973) . These authors concluded that this effect was mediated by elevation of 3': 5'-cyclic AMP concentrations with the involvement of a fl-type adrenergic receptor. At the same time Tolbert et al. (1973) and Tolbert & Fain (1974) had shown that catecholamine stimulation of gluconeogenesis in isolated liver cells involved a 3' :5'-cyclic AMP-independent a-adrenergic action. The main objective was therefore to test for the possibility of a-adrenergic stimulation of glucose production in kidney by using cortex-tubule fragments. This involved testing the effects of both a-and ,B-adrenergic blocking agents on catecholaminestimulated gluconeogenesis and also testing the actions of synthetic a-and fl-adrenergic agonists. The actions of glucagon were also investigated in the tubule-fragment system, in view of the divergence of opinion about the action of this hormone in other renal preparations. During the course of this work Guder & Rupprecht (1975a) presented evidence that catecholamine stimulation of renal gluconeogenesis is mediated via an a-receptor and is independent of changes in 3': 5'-cyclic AMP concentrations. The present study confirms and extends these findings.
Materials and Methods

Chemicals
NADP+, ATP, sodium pyruvate, hexokinase and glucose 6-phosphate dehydrogenase were obtained from Boehringer Corp. (London) Ltd. (Lewes, Sussex, U.K.). 3': 5'-Cyclic AMP (sodium salt), L-adrenaline, DL-propranolol hydrochloride, theophylline, papaverine (6,7-dimethoxy-l-veratrylisoquinoline), L(+)-lactic acid and DNA (type V, sodium salt, 'highly polymerised, from calf thymus') were from Sigma (London) Chemical Co. (Kingstonupon-Thames, Surrey, U.K.). Collagenase (type I from Clostridium histolyticum) was from Worthington Biochemical Corp. (Freehold, NJ, U.S.A). Bovine plasma albumin powder (fraction V) from Armour Pharmaceutical Co. (Eastbourne, Sussex, U.K.) or from Sigma (London) was subjected to a defatting procedure before use (Chen, 1967) . Bovine parathyrin and bovine glucagon were from Calbiochem (Hereford, U.K.). 3': 5'-Cyclic [8-3H]AMP (ammonium salt) and a 3': 5'-cyclic GMP radioimmunoassay kit were purchased from The Radiochemical Centre (Amersham, Bucks., U.K.). 3': 5'-Cyclic AMP-binding protein prepared from bovine muscle (Tovey et al., 1974) 
Animals
These were male Sprague-Dawley rats bred in the animal colony at University College. They were maintained on GR3EK diet (E. Dixon and Sons, Ware, Herts., U.K.) until the time of experimentation, when they weighed 160-180g.
Isolation of tubule preparationsfrom renal cortex
Rats were injected sequentially at 5min intervals with 0.05 ml of heparin (38mg/mi) intraperitoneally, and 20min after heparin treatment each rat was killed by cervical dislocation. The kidneys were quickly perfused as described by with 20--30ml of ice-cold bicarbonate buffer (Krebs & Henseleit, 1932 ) containing 1.27mM-Ca2+, rapidly removed and the medulla and papilla excised. Generally the pooled cortices of three rats were collected, cut into small pieces and shaken at 37°C under O2/C02 (19 1) in a 50ml silicone-treated Erlenmeyer flask containing 10ml of Krebs-Ringer bicarbonate buffer (containing 1.27mM-Ca2+), fatty acid-poor albumin (20mg/ml) and collagenase (2mg/ml). The tissue suspension was then gently forced through nylon mesh (no. 110; J. Staniar and Co., Manchester, U.K.) to remove undigested pieces and to aid dispersion. This was followed by centrifugation at lOOgav. for 1 min and the resulting pellet was then resuspended and washed twice by similar centrifugation with Krebs-Ringer bicarbonate buffer containing fatty acid-poor albumin (10mg/ml). Finally, the tubule preparation was generally made up in a stock suspension in which the tissue from each original kidney cortex was dispersed in 5 ml of Krebs-Ringer bicarbonate buffer containing albumin (lOmg/ml). Essentially this procedure differed from the preparations used by Nagata & Rasmussen (1970a) and in the absence of 1977 anaesthetics, the presence of albumin and the considerably shorter digestion time. In addition, sieving of undigested tissue ) and Ca2+-free media (Nagata & Rasmussen, 1970a) 
Analytical methods
Glucose was measured enzymically (Slein, 1965) in extracts prepared by deproteinization of incubation-flask contents with 0.5 ml of ice-cold 45% (w/v) HCl04. These extracts were neutralized by addition of 1 M-triethanolamine hydrochloride and concentrated K2CO3 (approx. 5 M). In all experiments the small amount of glucose initially present in nonincubated preparations was also determined and subtracted from experimental values.
When cyclic nucleotides were to be measured, flask contents were deproteinized by 2ml of 20% (w/v) trichloroacetic acid, left on ice for 1 h, centrifuged at lOOOg for 5 min and supernatants of duplicate experiments pooled. These were extracted with 5 x 20ml of water-saturated diethyl ether and then freeze-dried.
The extracts were dissolved in 0.5 ml of 50mM-sodium acetate buffer (adjusted to pH4.2 with HCI).
Duplicate 15,ul or 30pl samples were assayed for 3':5'-cyclic AMP as described by Gilman (1970) .
Portions of incubation media taken through the extraction procedures were also assayed and the small Vol. 168 blank values so found were subtracted from all experimental values. Extracts in sodium acetate buffer were neutralized (pH 6.5-7.5) by addition of a small amount of 1.67M-Tris/HCI, pH8.5, before duplicate 100,ul samples were taken for radioimmunoassay of 3': 5'-cyclic GMP as described by The Radiochemical Centre in the assay kit.
DNA was measured by the method of Burton (1956) in triplicate 1.0ml portions of stock tubule suspensions.
Statistical methods
Analysis of data was performed on a paired basis and statistical significance determined by the Student's t test.
Results
General considerations
Ca2+-free buffers, which are often used in preparation of isolated liver cells or renal tubules, were deliberately avoided, since their use did not result in any greater yields. Furthermore, in our hands, tubule fragments prepared in the presence of Ca2+ consistently exhibited higher rates of glucose production, e.g. 2-3,umol of glucose/30min per mg of DNA was produced by tubules prepared in 1.27mM-Ca2+ and then incubated with 1.27mM-Ca2+, whereas those prepared in Ca2+-free media and subsequently incubated with 1.27mM-Ca2+ produced only approx. 0.8,pmol/30min per mg of DNA.
In most experiments 5mM-pyruvate was used as substrate, since it is rapidly utilized as a gluconeogenic precursor in tubule preparations (Nagata & Rasmussen, 1970a; and its route of utilization involves most of the putative gluconeogenic control points. Preliminary experiments established the linearity of glucose production with time for at least I h.
Glycogen was not detectable in samples of tubule fragments equivalent to those normally incubated, and glucose production from endogenous substrates alone on incubation for 1 h with 1.27 mM-Ca2+ was only 3.8 % of that when 5 mM-pyruvate was present. It was therefore presumed that glucose formation in the presence of pyruvate or other substrates represented gluconeogenesis from these exogenous substrates. All Guder & Rupprecht (1975a) have similarly concluded that noradrenaline stimulation of gluconeogenesis is a-adrenergic. Fig. 1 shows adrenaline stimulation of glucose formation, which is significant at 0.1 pM (P < 0.02), 1GM (P < 0.001) and 10puM (P < 0.05). menon, but was a sustained effect for at least 1 h. Amidephrine, which shows selective a-sympathomimetic actions and is inoperative with f-receptors (Dungan et al., 1965) , also stimulated glucose production, but with a lower potency than adrenaline. Significant effects of amidephrine were observed at 0.1 pM(P < 0.01), 1 /uM(P < 0.01) and 10uM(P < 0.02).
Oxymetazoline (an imidazoline derivative) has also been reported to be devoid of fl-sympathomimetic actions but to be particularly potent with some areceptors (Mujid & van Rossum, 1965) : 10nm-oxymetazoline was as effective as 1 pM-adrenaline in promoting glucose formation. Significant effects of oxymetazoline were observed at 10nM (P < 0.02), 0.1 ,UM (P < 0.02) and 1 pUM (P < 0.05). On the other hand, salbutamol, a selective fl2-agonist (Cullum et al., 1969) , and isoproterenol, a 8,-and f2-agonist (Lands et al., 1967) , were both ineffective in the concentration range 10nM-10,uM. In fact, isoproterenol stimulation of rat renal gluconeogenesis has been demonstrated only at concentrations of 0.1 mm or higher (Kurokawa & Massry, 1973a; Klahr et al., 1973; Guder & Rupprecht, 1975a) .
Since oxymetazoline was obviously a potent selective agonist for this system and may therefore be a potential experimental tool, some further aspects of its action were examined (Table 2); 0.1 uM-oxymetazoline stimulated gluconeogenesis when lactate or glutamate was substrate. Absolute rates of glucose production were lower with these substrates than with pyruvate, but percentage stimulations by oxymetazoline were greater. Oxymetazoline was ineffective in promoting gluconeogenesis from succinate or glycerol.
The influence of Ca2+ concentration on stimulation of gluconeogenesis by oxymetazoline or adrenaline was tested (Table 3 ). Significant effects of adrenaline were apparent even in the absence of Ca2 . In percentage terms the sensitivity to adrenaline at zero Ca2+ was similar to that encountered at 1.27 mM-Ca2+ ( Fig. 1 and Table 1 ) and the sensitivity to adrenaline in the presence of a total Ca2+ concentration of 0.2mM was greater. In absolute terms, of course, greater stimulation by adrenaline is observed at 1.27im-Ca2+. By contrast, oxymetazoline action was absolutely Ca2+-dependent. No stimulation of gluconeogenesis by this drug was ever observed when Ca2+ was omitted. Significant effects ofoxymetazoline were seen only at relatively high Ca2+ concentrations (1 mm and higher).
Effects ofpeptide hormones
No glucagon stimulation of gluconeogenesis was seen at either 1.27mM-Ca2+ or 0.25 mM-Ca2+ (Fig. 2) . Indeed, at 0.25mM-Ca2+ glucagon caused significant decreases in glucose production (P < 0.02 and <0.05 with 0.1 and 0.5 ug/ml respectively). Fig. 2 also shows that the preparations retained sensitivity to another polypeptide, parathyrin. In the presence of 1.27mM-Ca2+, 0.25,pg of parathyrin/ml stimulated gluconeogenesis by 16±3% (P < 0.05). Expressed in percentage terms, other workers have found similar effects of parathyrin on pyruvate-or lactatedependent gluconeogenesis with 1-2mM-Ca2+ (Rasmussen & Nagata, 1970; Guder & Rupprecht, 1975a gluconeogenesis (Pagliara & Goodman, 1970; Kurokawa & Massry, 1973a,b) . Quite high concentrations of these compounds have to be used to inhibit cyclic nucleotide phosphodiesterases, and undesirable non-specific effects are therefore likely (Kurokawa & Massry, 1973b) . The smooth-muscle relaxant papaverine, which is structurally different from the methylxanthines, is a far more potent and possibly more specific inhibitor of cyclic nucleotide phosphodiesterases (O'Dea et al., 1970; Triner et al., 1970; Poch & Kukovetz, 1972) . Fig. 3 shows that theophylline inhibited glucose formation, confirming previous reports (see above), and that papaverine showed similar, though more potent, effects. No stimulation of glucose formation was seen at any tested concentration of papaverine (0.3/LM-0. 1 mM); 50 % inhibition of gluconeogenesis was found with 55puM-papaverine. In addition, 5OUM-papaverine did not potentiate the effect of 0. parathyrin/ml on glucose production (results not shown).
1977
Changes in cyclic nucleotide contents
Measurements were made of 3': 5'-cyclic AMP and 3': 5'-cyclic GMP in incubations of tubule fragments (Table 4) . These were short-time incubations under similar conditions to the studies presented above, except that the tissue concentration in the incubations was doubled. Cyclic nucleotide phosphodiesterase inhibitors, which have previously been included in many studies of cyclic nucleotides in tissues, were deliberately omitted. Eight experiments were performed, involving four agonists at three times together with the appropriate controls. The means of all eight of these control incubations are shown, indicating that basal contents of both cyclic nucleotides were essentially unchanged over the period of incubation. The values represent the cyclic nucleotide content of the whole incubation (tubules+ medium).
Papaverine (10jM) doubled 3': 5'-cyclic AMP after 4min. This was the shortest incubation time that could be satisfactorily resolved with the techniques used. Thereafter 3': 5'-cyclic AMP decreased. Glucagon (1 ,ug/ml) caused a significant increase in 3': 5'-cyclic AMP at 4min. This then decreased rapidly and returned to the basal value by 15min. Vol. 168 Glucagon and adrenaline both increased the ratio 3':5'-cyclic AMP/3':5'-cyclic GMP. Glucagon increased the ratio by 50±20% at 4min, 38±12% at 7.5min(P <0.05) and 15±4% at 15min (P < 0.05). With adrenaline, increases were 37±6% at 4min (P<0.01), 40±12% at 7.5min (P<0.05) and 20± 3 % at 15 min (P < 0.05). Oxymetazoline caused no significant changes in the 3': 5'-cyclic AMP/ 3': 5'-cyclic GMP ratio. Discussion
Assuming that a-adrenergic receptors are located on the plasma membrane of cells and that a-agonists are unlikely to work through a direct interaction with enzymes of gluconeogenesis, a 'second messenger' must be postulated to transmit the agonist stimulus. Both Ca2+ and 3' : 5'-cyclic GMP have been implicated in mediation of a-adrenergic actions in various systems (Kaminsky et al., 1970; Goldberg et al., 1973; Selinger et al., 1973; Butcher, 1975) . Kneer et al. (1974) have shown that exogenous 3': 5'-cyclic GMP can stimulate gluconeogenesis in rat hepatocytes. However, although 3': 5'-cyclic GMP in hepatocytes is increased after a-adrenergic stimulation, these changes do not correlate with changes in gluconeogenesis (Bosch et al., 1976) . The present observations with oxymetazoline (Table 4) show that the effects of this a-agonist are not related to changes in 3' : 5'-cyclic GMP concentration, nor indeed to 3': 5'-cyclic AMP either, unless some subtle inter-or intracellular compartmentation of cyclic nucleotides is invoked. The unlikelihood of 3': 5'-cyclic GMP being involved in a-adrenergic stimulation of renal gluconeogenesis is further strengthened by the observation that adrenaline slightly decreased 3': 5'-cyclic GMP (Table 4) . Adrenaline differed from oxymetazoline in this respect, but it is not known where in the tubule this decrease in 3': 5'-cyclic GMP occurs. Possibly it may be related to the small adrenaline-induced increase in 3': 5'-cyclic AMP (Table 4) , which Guder & Rupprecht (1975a) (Bowman, 1970) gluconeogenesis from pyruvate. In cortex slices from starved rats showed that glucagon considerably stimulated glucose formation from several substrates. These effects were seen only at low Ca2+ concentrations (0.25mM). Using tubule fragments, also from starved rats, Guder &Rupprecht (1976) found small increases in gluconeogenesis from pyruvate after addition of glucagon. In percentage terms this effect was also more apparent at low Ca2+ concentrations. Guder & Rupprecht (1976) also demonstrated that glucagon may increase tubule 3': 5'-cyclic AMP, but questioned the physiological relevance of this observation, since large hormone doses were needed. We confirm ( Table 4 ) the effect of glucagon on tubule 3': 5'-cyclic AMP. At present the location in the nephron from which this change in cyclic nucleotide concentration originates is unknown. With regard to glucagon and renal gluconeogenesis, we conclude that this hormone does not stimulate the process in tissue from fed rats. Possibly the discrepancy between the present study and that of reflects differences in nutritional status. Alternatively it is possible in the slice system used by 1977 that 3':5'-cyclic AMP released from some other structure in the cortex after glucagon stimulation may act to increase proximal-tubule gluconeogenesis in the same manner as added exogenous 3': 5'-cyclic AMP. The effects of cyclic nucleotide phosphodiesterase inhibitors remain perplexing. One of the criteria developed by Sutherland and his colleagues (Sutherland et al., 1965; Sutherland & Robison, 1966 ) for 3': 5'-cyclic AMP to be established as second messenger mediating a hormone action was that cyclic nucleotide phosphodiesterase inhibitors should mimic or potentiate the hormone action (methylxanthines were cited in Sutherland's original criteria). Although theophylline (Kurokawa & Massry, 1973a) and papaverine (Table 4) increase renal-cortical 3': 5'-cyclic AMP, stimulation of renal gluconeogenesis is obviously not seen (Fig. 3) . Side effects of theophylline and papaverine on membrane transport of substrates or Ca2+ (Carpenedo et al., 1971; Kadlec et al., 1973; Plagemann & Sheppard, 1974 ) cannot be discounted, but it is particularly noteworthy that the relative potencies of these drugs in inhibiting gluconeogenesis (Fig. 3) agree with their relative potencies as cyclic nucleotide phosphodiesterase inhibitors in other systems (Triner et al., 1970; Poch & Kukovetz, 1972) . In isolation these results suggest that intracellular 3': 5'-cyclic AMP is an unlikely second messenger for stimulation of gluconeogenesis. This is at variance, however, with the current hypothesis that the action of parathyrin on gluconeogenesis is mediated by 3': 5'-cyclic AMP and is also difficult to reconcile with the well-documented observation that exogenous 3': 5'-cyclic AMP stimulates renal gluconeogenesis. However, the involvement of 3': 5'-cyclic AMP in parathyrin stimulation of gluconeogenesis should be regarded with caution, since optimal concentrations of parathyrin and exogenous 3' 5'-cyclic AMP show partially additive effects under certain conditions (Fig. 2 of Guder & Wieland, 1972) . In addition, noradrenaline antagonizes the effects of parathyrin on tubule 3' 5'-cyclic AMP (Guder & Rupprecht, 1975b) , whereas noradrenaline and parathyrin have completely additive effects on gluconeogenesis (Guder & Rupprecht, 1975a) .
